<p>(A) Chemotaxis assays were performed with mesenchymal progenitors and conditioned media from either control- or PTH-treated UMR 106-01 cells in the presence or absence of pathway-specific inhibitors. D: DMSO; U: U0126 (20 µM); WT: wortmannin (3 µM); SB: SB202190 (20 µM). Inhibitors were added to both upper and bottom chambers. ***: p<0.001 vs. CON CM D; #: p<0.001 vs. PTH CM D. (B) Conditioned media from PTH-treated UMR 106-01 cells stimulated the phosphorylation of Akt and p38MAPK in MSCs. (C) PTH alone did not activate Akt and p38MAPK pathways in mesenchymal progenitors.</p
Bone marrow (BM)-derived mesenchymal stem cells (MSCs) have been shown to favor tumor growth, sugges...
Parathyroid hormone (PTH) analogs are the main anabolic pharmacological agent for osteoporosis. PTH ...
Introduction: Bone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are t...
<p>(A) Migration of freshly flushed rat bone marrow cells toward PTH and conditioned media from UMR ...
<p>(A) EGF-like ligands are chemotactic factors for mesenchymal progenitors. αMEM containing various...
<p>(A) Conditioned media from PTH-treated UMR 106-01 cells increased the phosphorylation of EGFR in ...
<p>(A) qRT-PCR quantification of mRNA levels of PTH1R in UMR106-01 cells and rat mesenchymal progeni...
Intermittent administration of parathyroid hormone (PTH) dramatically increases bone mass and curren...
<div><p>Intermittent administration of parathyroid hormone (PTH) dramatically increases bone mass an...
Human mesenchymal stem cells (hMSCs) can differentiate into osteoblasts and are regulated by chemica...
The study included in this thesis was aimed at elucidating the mechanisms involved in the actions of...
PTH recruits and activates osteoclasts to cause bone resorption. These actions of PTH are thought to...
Le récepteur à l'hormone parathyroïdienne (PTH1R) est couplé aux protéines G et sa stimulation indui...
Conditional deletion of the PTH1R in mesenchymal progenitors reduces osteoblast differentiation, enh...
Intermittent PTH administration builds bone mass and prevents fractures, but its mechanism of action...
Bone marrow (BM)-derived mesenchymal stem cells (MSCs) have been shown to favor tumor growth, sugges...
Parathyroid hormone (PTH) analogs are the main anabolic pharmacological agent for osteoporosis. PTH ...
Introduction: Bone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are t...
<p>(A) Migration of freshly flushed rat bone marrow cells toward PTH and conditioned media from UMR ...
<p>(A) EGF-like ligands are chemotactic factors for mesenchymal progenitors. αMEM containing various...
<p>(A) Conditioned media from PTH-treated UMR 106-01 cells increased the phosphorylation of EGFR in ...
<p>(A) qRT-PCR quantification of mRNA levels of PTH1R in UMR106-01 cells and rat mesenchymal progeni...
Intermittent administration of parathyroid hormone (PTH) dramatically increases bone mass and curren...
<div><p>Intermittent administration of parathyroid hormone (PTH) dramatically increases bone mass an...
Human mesenchymal stem cells (hMSCs) can differentiate into osteoblasts and are regulated by chemica...
The study included in this thesis was aimed at elucidating the mechanisms involved in the actions of...
PTH recruits and activates osteoclasts to cause bone resorption. These actions of PTH are thought to...
Le récepteur à l'hormone parathyroïdienne (PTH1R) est couplé aux protéines G et sa stimulation indui...
Conditional deletion of the PTH1R in mesenchymal progenitors reduces osteoblast differentiation, enh...
Intermittent PTH administration builds bone mass and prevents fractures, but its mechanism of action...
Bone marrow (BM)-derived mesenchymal stem cells (MSCs) have been shown to favor tumor growth, sugges...
Parathyroid hormone (PTH) analogs are the main anabolic pharmacological agent for osteoporosis. PTH ...
Introduction: Bone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are t...